Public Offering after fees: $7.2 Million
Price was: 4.45
Fees to Wainwright and Roth.
Other shares that could be O/S as in Warrants, Options and other: Around 8 to 9 Million Additional shares.
Actual Market Cap as of December 23, 2014: $78.6 Million.
Yahoo's Market Cap is "Misrepresentative"
How many Shares was the Public offering?
How many outstanding shares does this company REALLY have now?
Do you know the Actual Market Cap...after the issuance?
Now how much cash on hand do they have?
It seems a lot of pumpers but not too many know what's going on.
My earlier reply must not of posted.
AF is figuring me on Twitter also as I play with this idiot. He has now quit replying to my tweets.
He knows he has just about the worst most unprofessional over paid, unethical boss around...yet he wouldn't dare to say anything as he would lose his easy bashing blog and his hedgie buds.
AF is a JOKE and so is The Street is.
Gawd...their are a lot of Idiots on this board.
Bottom line is that we won't know until 9 months and six months should be a good indication. 3 months should of been an indication.
Wow and they already paid how much for it in bonuses for NDA, approval and next milestones before they can effectively use any of it.
It's a disaster unless they can get it over $30 million until patent expires.
Patent to expire in 2015 and Galena states that they will not be able to expand, extend or reapply for this patent. It would be reassuring if they had this patent until 2025 or so.
Large shareholder of the Street is calling him out to either sell the company or quite CNBC. The Street has been a total failure it has lost over 90% of its value since opening and Cramer pays himself $3.5 Million a year. I think AF should of put his boss in that poll of "worst CEO's for 2014".
Cramer is Worse than Kriegsman.
AF is so LUCKY to have a job where he can be blogger and manipulate companies.
You didn't help yourselves and simultaneously you didn't help patients...in fact you are going to HURT patients. Can't believe this deal...are they Stupid?
Study this deal people...for pharma investors as a whole this is not a good deal.
"Well Prepared" Clinical Trials...Please show me the proof to well prepared. This management team has not been well prepared for years, but if you know they are "well prepared" I would like you to explain in detail.
Most of us are here just because of RX-109 potentials. If the scarring trials fail, RXII will stay below $5 for several years---probably under $3. Why? That would ruin confidence of investors for other conditions and capturing 10% of the market with Samcyprone-- that will take years--6-8 years from now. Even Multi-Blockbuster Drugs take a good year or two Post Approval to make good money. Usually year 3 post approval is the year that sales escalate.
Tough road ahead from here...but I am expecting a bounce on Monday, possibly back towards $1.95 to $2.00. 50/50 chance as the candle from Friday is not very good...so Monday will be the day that indicates if this stock goes back toward the $2 range or continues to drift below the BB. This will kind of be in a stalemate until RXI-109 is able to validate to the common eye; could be 9 months...next August or September---expect a run. Possible a Six Month Run also...IF they display pictures, but if they don't say anything at six months-- that will NOT be a good sign. We really should see benefits at six months which would be late May or June, but definitely by 9 months.
Take a look at what happened to Polymedix PYMX -- they had great technology with some excellent scientists, but a couple bad decisions and they went completely bankrupt and lost it ALL. This happened in ONE year and they lost $500 Million in MC in one year. CTIX bought all their assets in bankruptcy for $5 Million. Since then CTIX market cap has increased by $360 Million.
It's ALL about the decisions that are made.
$10 Million doesn't go far, so just when the stock begins to run...Expect more dilution.
Unfortunately...this is the position that RXII is in right now and the foreseeable future.
That doesn't mean that the stock won't double or triple...because If you consider the market cap of around $40--$90 million pending on how many new shares will be introduced to the float in the next six months -- it may still be perceived as a low market cap. I just see a tough road ahead in the near term.
It will be a learning experience for me to observe what occurs here... prepare myself for when another small pharma takes a similar road.
I think Geert is doing the best he can and he is a good guy....Much Better than CYTR's CEO Kriegsman -- where this was spun off from.
He has definitely made some mistakes...I wonder if a larger Pharma would be willing to take a risk and buy this out right now?
Wonder how much?
Alright Good Luck Everyone.
I would rather get this over right NOW....it is a dark cloud of insecurity hanging over which could significantly lower the stock price.
This stock is 27% owned by Non-Retail? How will they perceive this and what will they do?
What will the Non-Retailers do?
The sector of Small Biotech's are beginning to start their annual run --- RXII is going the opposite. Will people hold on here or will they sell and ride the band wagon to procure profits?
LPC will begin buying immediately as RXII needs money right now this second, and these are NEW shares introduced to the float...Dilution.
Hapten Pharmaceuticals will receive shares --- More Dilution.
There are a lot of uncertainties.
This is like a shot from half court with one second left ... the shot looks good... it is rolling around the rim....it is ____ Wait ... this second is going to take a minimum of Six months....Standby.
Actually I may have been a bit hard on Geert as I believe he is trying very hard to establish rapport with shareholders. The problem is TIME and money.
The Phase II -b trial will not be until 2016...over one year from now and that is if everything goes as planned. Unless this is a Misprint and meant to say 2015???
The Short Term Prognosis for RXII: Not too good
Medium Term: 9-12 months: All depends on 9 month results of RX-109
Long Term:Depends on deals, partnerships and dilution...Unknown.
I think that Geert is doing this as a back up plan in case RX-109 fails and he will have something that will be in a phase II so the company will not go into bankruptcy.
Here is what Geert says: There will be dilution but this should be offset by the addition of Samcyprone.
An Earlier deal with LPC was a disaster in which they left $18 Million on the table. RXI needs money NOW, so I expect them to IMMEDIATELY have LPC start buying shares which will raise O/S.
Also: There are an Undisclosed amount of shares going to Hapten Pharma...how many, we don't know.
This is almost like taking a final shot from half court with one second remaining to win the game...the shot looks good... the ball is rolling on the rim... and rolling - but this second will take a minimum of six months...question is-- will it go in?
So for the short term this may suffer. It will be a learning experience for me to monitor such a situation so I can be prepared when it occurs in the future with another company.
About 27% of this company is owned by Non-Retail and the question is...how will they respond?
As I mentioned: I believe Lincoln Park will be buying immediately, but these will be Newly issued shares. LPC will want them cheap, so I bet they hedge it and try to keep this as low as possible until they are invested. This could actually be in about one year IF RXI wants to. RXI really left unused money on the table last time.
Then you have shares to be converted...contin
This needs to be Clarified...I don't see them abandoning RX-109 just yet, but after 2015 if nothing has changed? IDK
I am a bit confounded about the Direction or multiple directions they are going, the costs associated, the potential convertible shares, the 100,000 FREE shares given to RXII and just how much dilution took place over acquiring DCP. I would also like to know the precise royalties and projected costs of progressing this to an approval and time frame....yeah, that was a lot.
I hope an HONEST press release is issued to clarify.
I do believe that the sell off was to help LPC so they can buy cheap shares when RXII informs them to buy and also confusion about the 3 PR's -- 3 month at 54%, new financing and license acquisition.